Development of Tumor‐Targeting 5‐Fluorouracil‐Loaded Hyaluronate Nanoparticles With pH‐Responsive Functional Groups on Both Surface and Interior

In this study, we engineered pH‐responsive nanoparticles (NPs) capable of undergoing surface charge conversion in the acidic microenvironment of tumors. These NPs were constructed from hyaluronic acid (HA) conjugated with deoxycholic acid (DOCA) and further functionalized with either 2,3‐dimethylmaleic anhydride (DMA) or 3‐(diethylamino)propylamine (DEAP). Self‐assembly of the hydrophilic segments (HA, DMA) and hydrophobic moieties (non‐protonated DEAP, DOCA) at physiological pH (7.4) yielded stable NPs encapsulating the chemotherapeutic agent 5‐fluorouracil (5‐FU). These constructs are herein referred to as HDOC‐DMA/HDOC‐DEAP NPs. At pH 7.4, the NPs maintained a net negative surface charge. Upon exposure to mildly acidic conditions characteristic of the tumor microenvironment (pH ~7.0), hydrolysis of DMA moieties triggered a surface charge reversal to positive, enhancing electrostatic interactions with negatively charged cellular membranes. Moreover, under endosomal pH conditions, protonation of DEAP induced electrostatic repulsion within the NPs, leading to structural destabilization and accelerated release of 5‐FU. In vitro studies demonstrated significantly enhanced cellular uptake of the NPs under acidic conditions, resulting in improved cytotoxic efficacy against tumor cells. These findings suggest that HDOC‐DMA/HDOC‐DEAP NPs represent a promising platform for tumor‐targeted drug delivery via pH‐triggered surface charge modulation.

• Publication year

  2025

• Venue

  Polymers for Advanced Technologies

• Publication date

  2025-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1002/pat.70419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A pH-Responsive Polycarbonate Nanoplatform enables Sequential Drug Release for Enhanced Apoptotic Cascade Synergy in Non-Small Cell Lung Cancer Therapy.

  2025cited by this paper
• Tumor Microenvironment-Responsive Nanoparticles: Promising Cancer PTT Carriers

  2025cited by this paper
• Artificial Liposomes With Internal Docking Site for Protein Delivery

  2025cited by this paper
• pH-responsive carbohydrate polymer-based nanoparticles in cancer therapy.

  2025influential reference
• Ce6-modified Fe ions-doped carbon dots as multifunctional nanoplatform for ferroptosis and photodynamic synergistic therapy of melanoma

  2024cited by this paper
• pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery

  2024cited by this paper
• Dopamine-Conjugated Bovine Serum Albumin Nanoparticles Containing pH-Responsive Catechol-V(III) Coordination for In Vitro and In Vivo Drug Delivery

  2023cited by this paper
• pH‐dependent swellable hyaluronate nanogels targeting acidic tumors

  2023cited by this paper
• Novel fluorescent nanoprobe based on hyaluronic acid and polyethyleneimine functionalized graphene oxide for detecting hyaluronidase as tumor marker

  2023cited by this paper
• β-cyclodextrin/alginate nanoparticles encapsulated 5-fluorouracil as an effective and safe anticancer drug delivery system

  2022cited by this paper
• Preparation of fluorescent nanoparticles based on broken-rice starch for live-cell imaging.

  2022cited by this paper
• A pHe sensitive nanodrug for collaborative penetration and inhibition of metastatic tumors.

  2022influential reference
• Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments

  2021cited by this paper
• Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment.

  2021cited by this paper
• pH-responsive cationic liposome for endosomal escape mediated drug delivery.

  2020cited by this paper
• Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells

  2017influential reference
• Synthesis and pH-dependent hydrolysis profiles of mono- and dialkyl substituted maleamic acids.

  2017cited by this paper
• Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration.

  2016cited by this paper
• Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.

  2015influential reference
• Acylsulfonamide-Functionalized Zwitterionic Gold Nanoparticles for Enhanced Cellular Uptake at Tumor pH.

  2015influential reference
• Surface charge switching nanoparticles for magnetic resonance imaging.

  2014cited by this paper
• Hyaluronated nanoparticles with pH- and enzyme-responsive drug release properties.

  2014cited by this paper
• Electrostatic charge conversion processes in engineered tumor-identifying polypeptides for targeted chemotherapy.

  2012cited by this paper
• 5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications.

  2011cited by this paper
• Delivering nanomedicine to solid tumors

  2010cited by this paper
• Recent progress in tumor pH targeting nanotechnology.

  2008cited by this paper

• No citing papers are available for this paper.